• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    iHuman Inc. Announces First Quarter 2024 Unaudited Financial Results

    6/28/24 12:01:00 AM ET
    $IH
    Other Consumer Services
    Real Estate
    Get the next $IH alert in real time by email

    BEIJING, June 28, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2024.

    (PRNewsfoto/iHuman Inc.)

    First Quarter 2024 Highlights

    • Revenues were RMB235.0 million (US$32.5 million), compared with RMB265.2 million in the same period last year.
    • Gross profit was RMB168.1 million (US$23.3 million), compared with RMB185.6 million in the same period last year.
    • Operating income was RMB17.5 million (US$2.4 million), compared with RMB56.7 million in the same period last year.
    • Net income was RMB22.3 million (US$3.1 million), compared with RMB53.6 million in the same period last year.
    • Average total MAUs[1] reached a record-high of 26.38 million, a year-over-year increase of 25.1%.

     

    [1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

     

    Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "We started 2024 on a positive note, as our team precisely and efficiently executed our product roadmap to ensure our continued leadership in capturing user engagement. Central to our industry-leading product offerings are our high-quality content and advanced technological capabilities. In the first quarter, we continued to drive meaningful enhancements to our portfolio by leveraging these two strengths. Specifically, we intensified efforts to enhance our AI technologies and deepened their integration into our products to provide more dynamic and personalized experiences for our users. In June, we launched a brand-new product, iHuman Smart Coder, a full-year course developed and designed by iHuman's stellar team that was led by graduates from Tsinghua University. This course is designed to foster a scientific mindset and digital literacy for children by blending curated content with innovative, exploratory, interactive, and immersive activities. With a scientifically-structured curriculum benchmarked against accredited proficiency exams, the course aims to transform kids from coding novices to proficient problem solvers prepared for a digitalized future. It also offers kids comprehensive support through a three-tiered system: a chatbot for immediate queries, a real-time code debugging feature powered by our proprietary large language model, and personalized guidance from seasoned instructors. We are confident that this course will equip the young minds with the skills and confidence to navigate an ever-evolving futuristic world.

    We have also enriched our existing products with more AI-enabled experiences. Within iHuman Magic Thinking, we introduced "Challenge", a new AI-powered feature that focuses on number literacy. Leveraging advanced AI algorithms, the new feature dynamically adapts the difficulty of questions to users' level, ensuring that young learners remain appropriately challenged. This facilitates effective practice while preventing kids from becoming excessively frustrated, thus maintaining their engagement and enthusiasm.

    Beyond our domestic efforts, expanding our presence in international markets continues to be our strategic priority. Adhering to our product-driven strategy, we continued to drive market penetration by strengthening our product pipeline to meet the unique needs of international users. We recently expanded the Aha World brand with Aha Makeover, a customizable, DIY-fashion design app that offers young children a dynamic platform to unlock their creativity through personalized virtual styling experiences. Kids can choose from a diverse array of avatars, personalize their hairstyles, decorate their avatar with different accessories, and experiment with an extensive wardrobe for various occasions. Our cutting-edge AR technology then seamlessly integrates virtual and physical elements, offering kids an interactive experience where their creations come to life.

    Furthermore, we are making more selected domestic products which we believe have cross-border appeal and audiences available beyond the Chinese mainland market. For example, we have recently rolled out bekids Library, the adapted version of iHuman Readers, a comprehensive leveled English reading app that we collaborate on with Oxford University Press. Now available in Macau and Taiwan, it offers a curated collection of more than 1,000 graded readers from Oxford University Press and caters to different proficiency levels and interests. bekids Library also allows kids to record and listen their independent reading, personalizing the reading experience for every child.

    Moving forward, our focus remains on enhancing our core competencies and creating high-quality and popular products to promote the holistic development of young children."

    Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "Throughout the first quarter, our steadfast commitment to product excellence continued to propel our business forward. Supported by high levels of user satisfaction and loyalty, our average total MAUs reached a record-high of 26.38 million, representing a year-over-year increase of 25.1%. Additionally, we recorded profitability for the ninth consecutive quarter. With ongoing profitability and healthy cash reserves, we have stepped up investments in several key strategic priorities. These include advancing AI research and development to elevate product value and user experience, expanding our product range to cater to a broader age demographic and increase total addressable market, and intensifying international marketing efforts to bolster our brand recognition globally. While these increased investments may temporarily impact our short-term profitability, we believe they are crucial for reinforcing our industry leadership, sustaining our long-term growth, and creating long-term value for our shareholders."

    First Quarter 2024 Unaudited Financial Results

    Revenues

    Revenues were RMB235.0 million (US$32.5 million), a decrease of 11.4% from RMB265.2 million in the same period last year, primarily reflecting the ongoing normalization from the exceptional performance in the same period last year, which was caused by a heightened demand driven by more indoor activities during the pandemic. 

    Average total MAUs for the quarter reached a record-high of 26.38 million, an increase of 25.1% year-over-year from 21.09 million in the same period last year.

    Cost of Revenues

    Cost of revenues was RMB66.9 million (US$9.3 million), a decrease of 16.0% from RMB79.6 million in the same period last year, primarily due to decreased channel costs.

    Gross Profit and Gross Margin

    Gross profit was RMB168.1 million (US$23.3 million), compared with RMB185.6 million in the same period last year. Gross margin was 71.5%, compared with 70.0% in the same period last year.

    Operating Expenses

    Total operating expenses were RMB150.6 million (US$20.9 million), an increase of 16.9% from RMB128.8 million in the same period last year.

    Research and development expenses were RMB67.9 million (US$9.4 million), an increase of 10.1% year-over-year from RMB61.7 million in the same period last year, primarily due to increased payroll related expenses.  

    Sales and marketing expenses were RMB55.0 million (US$7.6 million), an increase of 36.0% from RMB40.4 million in the same period last year, primarily due to increased strategic spending on promotional activities, brand enhancement, and overseas expansion.

    General and administrative expenses were RMB27.7 million (US$3.8 million), compared with RMB26.7 million in the same period last year.

    Operating Income

    Operating income was RMB17.5 million (US$2.4 million), compared with RMB56.7 million in the same period last year.

    Net Income

    Net income was RMB22.3 million (US$3.1 million), compared with RMB53.6 million in the same period last year.

    Basic and diluted net income per ADS were RMB0.42 (US$0.06) and RMB0.41 (US$0.06), respectively, compared with RMB1.01 and RMB0.98 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

    Deferred Revenue and Customer Advances

    Deferred revenue and customer advances were RMB313.8 million (US$43.5 million) as of March 31, 2024, compared with RMB318.6 million as of December 31, 2023.

    Cash, Cash Equivalents and Time Deposits

    Cash, cash equivalents and time deposits were RMB1,131.3 million (US$156.7 million) as of March 31, 2024, compared with RMB1,213.8 million as of December 31, 2023. The decrease was primarily due to the payment of annual bonuses to employees in the first quarter.

    Exchange Rate Information

    The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of March 29, 2024, which was RMB7.2203 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

    Non-GAAP Financial Measures

    iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

    Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates"  and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    About iHuman Inc.

    iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

    For more information about iHuman, please visit https://ir.ihuman.com/. 

    For investor and media enquiries, please contact:

    iHuman Inc.

    Mr. Justin Zhang

    Investor Relations Director

    Phone: +86 10 5780-6606

    E-mail: [email protected] 

    Christensen

    In China

    Ms. Alice Li

    Phone: +86-10-5900-1548

    E-mail: [email protected]  

    In the US

    Ms. Linda Bergkamp

    Phone: +1-480-614-3004

    E-mail: [email protected]  

     

    iHuman Inc.



    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)







    December 31,



    March 31,



    March 31,





    2023



    2024



    2024





    RMB



    RMB



    US$















    ASSETS













    Current assets













    Cash and cash equivalents 



    1,213,767



    890,805



    123,375

    Time deposits



    -



    240,521



    33,312

    Accounts receivable, net



    60,832



    68,068



    9,427

    Inventories, net



    16,518



    17,247



    2,389

    Amounts due from related parties



    1,810



    2,850



    395

    Prepayments and other current assets



    89,511



    93,567



    12,959

    Total current assets



    1,382,438



    1,313,058



    181,857

    Non-current assets













    Property and equipment, net



    6,169



    5,504



    762

    Intangible assets, net



    23,245



    22,080



    3,058

    Operating lease right-of-use assets



    3,648



    3,235



    448

    Long-term investment



    26,333



    26,333



    3,647

    Other non-current assets



    8,662



    8,286



    1,146

    Total non-current assets



    68,057



    65,438



    9,061

    Total assets



    1,450,495



    1,378,496



    190,918















    LIABILITIES













    Current liabilities













    Accounts payable



    22,139



    21,556



    2,985

    Deferred revenue and customer advances



    318,587



    313,790



    43,459

    Amounts due to related parties



    4,428



    22,710



    3,145

    Accrued expenses and other current liabilities



    143,677



    94,054



    13,026

    Dividend payable



    -



    37,525



    5,197

    Current operating lease liabilities



    1,927



    1,823



    252

    Total current liabilities



    490,758



    491,458



    68,064

    Non-current liabilities













    Non-current operating lease liabilities



    1,933



    1,495



    207

    Total non-current liabilities



    1,933



    1,495



    207

    Total liabilities



    492,691



    492,953



    68,271

    SHAREHOLDERS' EQUITY













    Ordinary shares (par value of US$0.0001 per share,

        700,000,000 Class A shares authorized as of

        December 31, 2023 and March 31, 2024; 125,122,382

        Class A shares issued and
    119,704,787 outstanding as

        of December 31, 2023; 125,122,382 Class A shares

        issued and 119,284,712 outstanding as of March 31,

        2024;  200,000,000 Class B shares authorized,

        144,000,000 Class B ordinary shares issued and

        outstanding as of December 31, 2023 and March 31,

        2024; 100,000,000 shares (undesignated) authorized,

        nil shares (undesignated) issued and outstanding as of

        December 31, 2023 and March 31, 2024)



    185



    185



    26

    Additional paid-in capital



    1,088,628



    994,532



    137,741

    Treasury stock



    (16,665)



    (17,922)



    (2,482)

    Statutory reserves



    8,164



    8,164



    1,131

    Accumulated other comprehensive income



    17,955



    18,745



    2,596

    Accumulated deficit



    (140,463)



    (118,161)



    (16,365)

    Total shareholders' equity



    957,804



    885,543



    122,647

    Total liabilities and shareholders' equity



    1,450,495



    1,378,496



    190,918

     

    iHuman Inc.



    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)







    For the three months ended





    March 31,



    March 31,



    March 31,





    2023



    2024



    2024





    RMB



    RMB



    US$















    Revenues



    265,203



    235,003



    32,548

    Cost of revenues



    (79,636)



    (66,892)



    (9,264)















    Gross profit



    185,567



    168,111



    23,284















    Operating expenses













    Research and development expenses



    (61,673)



    (67,923)



    (9,407)

    Sales and marketing expenses



    (40,435)



    (54,995)



    (7,617)

    General and administrative expenses



    (26,735)



    (27,724)



    (3,840)

    Total operating expenses



    (128,843)



    (150,642)



    (20,864)

    Operating income



    56,724



    17,469



    2,420

    Other income, net



    6,082



    9,010



    1,248

    Income before income taxes



    62,806



    26,479



    3,668

    Income tax expenses



    (9,160)



    (4,177)



    (579)

    Net income



    53,646



    22,302



    3,089















    Net income per ADS:













       - Basic



    1.01



    0.42



    0.06

       - Diluted



    0.98



    0.41



    0.06















    Weighted average number of ADSs:













       - Basic



    52,953,297



    52,729,148



    52,729,148

       - Diluted



    54,763,570



    54,691,599



    54,691,599















    Total share-based compensation expenses included in:













    Cost of revenues



    98



    40



    6

    Research and development expenses



    638



    457



    63

    Sales and marketing expenses



    379



    46



    6

    General and administrative expenses



    1,292



    301



    42

     

    iHuman Inc.



    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS



     (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)







    For the three months ended





    March 31,



    March 31,



    March 31,





    2023



    2024



    2024





    RMB



    RMB



    US$















    Operating income



    56,724



    17,469



    2,420

    Share-based compensation expenses



    2,407



    844



    117

    Adjusted operating income



    59,131



    18,313



    2,537















    Net income



    53,646



    22,302



    3,089

    Share-based compensation expenses



    2,407



    844



    117

    Adjusted net income



    56,053



    23,146



    3,206















    Diluted net income per ADS



    0.98



    0.41



    0.06

    Impact of non-GAAP adjustments



    0.04



    0.01



    0.00

    Adjusted diluted net income per ADS



    1.02



    0.42



    0.06















    Weighted average number of ADSs – diluted



    54,763,570



    54,691,599



    54,691,599

    Weighted average number of ADSs – adjusted



    54,763,570



    54,691,599



    54,691,599

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-first-quarter-2024-unaudited-financial-results-302185388.html

    SOURCE iHuman Inc.

    Get the next $IH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IH

    DatePrice TargetRatingAnalyst
    12/30/2022$3.10Buy
    Citigroup
    More analyst ratings

    $IH
    Financials

    Live finance-specific insights

    See more
    • iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

      BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenues were RMB232.7 million (US$31.9 million), compared with RMB250.4 million in the same period last year.Gross profit was RMB156.4 million (US$21.4 million), compared with RMB178.2 million in the same period last year.Operating income was RMB14.9 million (US$2.0 m

      3/25/25 4:03:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

      BEIJING, Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2024.   Third Quarter 2024 Highlights Revenues were RMB239.4 million (US$34.1 million), compared with RMB261.5 million in the same period last year.Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year.Operating income was RMB20.7 million (US$2.9 million), compare

      12/26/24 3:18:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

      BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.Operating income was RMB18.8 million (US$2.6 million), compared wi

      9/27/24 5:47:00 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Citigroup resumed coverage on iHuman with a new price target

      Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10

      12/30/22 8:45:58 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

      SC 13G/A - iHuman Inc. (0001814423) (Subject)

      3/8/22 10:06:04 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

      SC 13G/A - iHuman Inc. (0001814423) (Subject)

      2/14/22 4:13:25 PM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form SC 13G filed

      SC 13G - iHuman Inc. (0001814423) (Subject)

      2/16/21 6:11:44 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    SEC Filings

    See more
    • SEC Form 20-F filed by iHuman Inc.

      20-F - iHuman Inc. (0001814423) (Filer)

      4/28/25 4:01:23 PM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by iHuman Inc.

      6-K - iHuman Inc. (0001814423) (Filer)

      3/25/25 7:10:38 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by iHuman Inc.

      6-K - iHuman Inc. (0001814423) (Filer)

      12/26/24 6:01:05 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • UPDATE - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 10:44:07 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 8:35:00 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • iHuman Inc. Files 2024 Annual Report on Form 20-F

      BEIJING, April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission on April 28, 2025. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements for the year ended December 31, 2024, free of charge, to its shareholders and ADS holders upon request. Requests should be directed t

      4/28/25 4:40:00 PM ET
      $IH
      Other Consumer Services
      Real Estate